(FILES) (COMBO) This combination of file photos created on January 7, 2021 shows the logo of German chemicals giant Bayer (top, on November 14, 2006 in Berlin) and the logo of biopharmaceutical company CureVac (on December 15, 2020 at the company's headquarters in Tuebingen, southern Germany). - Bayer announced on February 1, 2021, it will produce from 2022 a coronavirus vaccine that fellow German pharmaceuticals company CureVac is developing. (Photos by John MACDOUGALL and THOMAS KIENZLE / AFP)